Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001541157-13-000002
Filing Date
2013-09-30
Accepted
2013-09-30 15:45:11
Documents
1
Effectiveness Date
2013-09-30
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 14629
  Complete submission text file 0001541157-13-000002.txt   15852
Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036
Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804
Celsus Therapeutics Plc. (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: D | Act: 33 | File No.: 021-203753 | Film No.: 131123207
SIC: 2834 Pharmaceutical Preparations